Vimarsana
Biggest News Aggregation in the World

Page 24 - Material Command News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Material Command. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Material Command Today - Breaking & Trending Today

CytoSorbents to Report Fourth Quarter and Full Year 2021 Operating and Financial Results - Vimarsana News

CytoSorbents to Report Fourth Quarter and Full Year 2021 Operating and Financial Results

Published: February 8, 2022

/PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac...

Source: prnewswire.com
Related Topics:
United StatesEric KimUs Department Of HealthHuman ServicesMaterial CommandNational Institutes Of HealthUs AirCorporate CommunicationsEuropean UnionUs ArmyBlood InstituteCytosorbents CorporationNational HeartSorbents CorporationInvestor RelationsUse AuthorizationRemoval SystemTimely Antithrombotic Removal TicagrelorTimely Antithrombotic RemovalOral AnticoagulantsNational InstitutesOperations CommandAir Force Material CommandPrivate Securities Litigation Reform ActAnnual Report
CytoSorbents to Report Fourth Quarter and Full Year 2021 Operating and Financial Results - Vimarsana News

CytoSorbents to Report Fourth Quarter and Full Year 2021 Operating and Financial Results

Published: February 8, 2022

/PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac...

Source: prnewswire.com
Related Topics:
United StatesEric KimUs Department Of HealthHuman ServicesMaterial CommandNational Institutes Of HealthUs AirCorporate CommunicationsEuropean UnionUs ArmyBlood InstituteCytosorbents CorporationNational HeartSorbents CorporationInvestor RelationsUse AuthorizationRemoval SystemTimely Antithrombotic Removal TicagrelorTimely Antithrombotic RemovalOral AnticoagulantsNational InstitutesOperations CommandAir Force Material CommandPrivate Securities Litigation Reform ActAnnual Report
First Patient Enrolled in the PROCYSS Multicenter Randomized Controlled Trial Evaluating CytoSorb® to Restore Hemodynamic Stability in Patients with Refractory Septic Shock - Vimarsana News

First Patient Enrolled in the PROCYSS Multicenter Randomized Controlled Trial Evaluating CytoSorb® to Restore Hemodynamic Stability in Patients with Refractory Septic Shock

Published: February 1, 2022

/PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac...

Source: prnewswire.com
Related Topics:
United StatesJoerg ScheierEfthymios DeliargyrisStefan KlugeEric KimUs Department Of HealthHuman ServicesMaterial CommandNational Institutes Of HealthUs AirCorporate CommunicationsEuropean UnionAffairs Critical Care Of CytosorbentsUs ArmyBlood InstituteCytosorbents CorporationNational HeartProfessor Stefan KlugeVice PresidentMedical Affairs Critical CareChief Medical OfficerTreatment Of Critically Ill PatientsSorbents CorporationUse AuthorizationRemoval System
CytoSorbents Issues Stockholder Letter and Reports Preliminary Fourth Quarter and Full Year 2021 Revenue - Vimarsana News

CytoSorbents Issues Stockholder Letter and Reports Preliminary Fourth Quarter and Full Year 2021 Revenue

Published: January 18, 2022

/PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac...

Source: prnewswire.com
Related Topics:
New JerseyUnited StatesBentracimab PhasebioAstra ZenecaEric KimPhillip ChanKathleen BlochMaterial CommandBoehringer IngelheimCenters For MedicareEuropean UnionUs ArmyBristol Myers SquibbMedicaid ServicesCytosorbents CorporationNational HeartBlood InstituteUs Department Of HealthNational Institutes Of HealthHuman ServicesUs AirCorporate CommunicationsCumulative CytosorbTotal RevenueProduct Sales
CytoSorbents Issues Stockholder Letter and Reports Preliminary Fourth Quarter and Full Year 2021 Revenue - Vimarsana News

CytoSorbents Issues Stockholder Letter and Reports Preliminary Fourth Quarter and Full Year 2021 Revenue

Published: January 18, 2022

MONMOUTH JUNCTION, N.J., Jan. 18, 2022 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening cond...

Source: businessinsider.com
Related Topics:
New JerseyUnited StatesMonmouth JunctionBentracimab PhasebioAstra ZenecaEric KimPhillip ChanKathleen BlochMaterial CommandBoehringer IngelheimCenters For MedicareEuropean UnionUs ArmyBristol Myers SquibbMedicaid ServicesCytosorbents CorporationNational HeartBlood InstituteUs Department Of HealthNational Institutes Of HealthHuman ServicesUs AirCorporate CommunicationsSorbents CorporationChief Executive Officer